DelveInsight
DelveInsight's primary conduit for delivering intelligent information to professionals in both the business and healthcare sectors is through its meticulously crafted analytical and strategic reports. Presently, DelveInsight boasts a diverse portfolio encompassing over 3,000 Marketed and Pipeline Reports. These reports are thoughtfully categorized based on parameters such as indication, mechanism of actions, drugs, global API manufacturers, and specialized reports focusing on pivotal areas such as Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy, and other emerging domains. This robust platform has become the go-to resource for numerous enterprises seeking to transform and redefine their business strategies.
DelveInsight's offerings extend beyond reports to encompass Consulting Projects and Competitive Intelligence services, catering to the multifaceted needs of its clientele. Moreover, the organization is dedicated to providing tailor-made research services that align with the specific interests and requirements of its clients. DelveInsight's commitment to excellence and innovation positions it as a trusted partner in the areas of business strategy and market research.
View recent articles by this publisher on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
The Power of Digital Therapeutics in Mental Health
Anti-VEGF Therapies: Forever Market Rulers of Wet-AMD Treatment?
Additional articles from this publisher
10,954 Reports from DelveInsight
-
Chronic Spontaneous Urticaria - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s analysis, the Chronic Spontaneous Urticaria Market Size in the 7MM was valued at approximately USD 2,173.3 million in 2023. Over the forecast period from 2024 to 2034, this market is projected to grow at a CAGR of more than 10%, driven by the introduction o ... Read More
-
Acromegaly- Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights According to the estimates, the Acromegaly market size in the 7MM is ~USD 1,300 million in 2023. In 2023, among all the therapies, the highest Acromegaly market revenue was generated by somatostatin, i.e., ~USD 300 million, followed by growth hormone antagonist, i.e., ~USD 90 million ... Read More
-
Alzheimer's Disease - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the 7MM reported approximately 15,840 thousand diagnosed prevalent cases of Alzheimer’s disease, reflecting a significant disease burden. This high prevalence underscores the need for innovative treatments to address the rising impact on healthcare systems and patient care. I ... Read More
-
Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the US accounted for the maximum share of the Ewing sarcoma Treatment Market in the 7MM, i.e., nearly 53%. A molecular-targeted therapy with minimal risk of late toxicities would be beneficial because most Ewing sarcoma Patients are under 20 years old. Although there is no st ... Read More
-
Epidermolysis Bullosa - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by 2034. Epidermolysis bullosa simplex (EBS) is the least severe type of epidermolysis bullosa, and many individ ... Read More
-
Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The heparin-induced thrombocytopenia market size in the 7MM is estimated to be around ~USD 128 million, in 2023. Heparin-induced thrombocytopenia is characterized by a rapid decrease in platelet count occurring 5–14 days after the initiation of heparin therapy. It is primarily caused ... Read More
-
KRAS Inhibitors - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
Key Highlights Among the 7MM, the United States captured the highest KRAS inhibitors market size in 2023, accounting for nearly 70% of the total KRAS Inhibitor market share. Among the approved KRAS Inhibitor therapies in the United States, KRAZATI is expected to have the edge over LUMAKRAS in revenu ... Read More
-
Oligometastatic Disease - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s patient-based forecasting model, the oligometastatic disease market size in the 7MM was around USD 1,900 million in 2023, which is expected to significantly increase over the forecast period (2024-2034), owing to an increase in the cases and the launch of n ... Read More
-
Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights The Postpartum Depression Treatment Market Size in the 7MM was estimated to be USD 260 million in 2023. Among EU4 and the UK, the UK accounted for the highest Postpartum Depression Market Size of ~USD 25 Million in 2023. Among the seven major countries, the Postpartum Depression diagn ... Read More
-
Chronic Neuropathic Pain - Pipeline Insight, 2025
Chronic Neuropathic Pain Overview ""Chronic Neuropathic Pain Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Chronic Neuropathic Pain market. A detailed picture of the Chronic Neuropathic Pain pip ... Read More
-
Brain Cancer - Pipeline Insight, 2025
Brain Cancer Overview ""Brain Cancer Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Brain Cancer market. A detailed picture of the Brain Cancer pipeline landscape is provided, which includes the ... Read More
-
Calcific Aortic Valve Stenosis (CAVS) - Pipeline Insight, 2025
Calcific Aortic Valve Stenosis (CAVS) Overview ""Calcific Aortic Valve Stenosis (CAVS) Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Calcific Aortic Valve Stenosis (CAVS) market. A detailed pict ... Read More
-
Acute Decompensated Heart Failure (ADHF) - Pipeline Insight, 2025
Acute Decompensated Heart Failure (ADHF) Overview ""Acute Decompensated Heart Failure (ADHF) Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Decompensated Heart Failure (ADHF) market. A deta ... Read More
-
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2025
Acute Myelogenous Leukemia (AML) Overview ""Acute Myelogenous Leukemia (AML) Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Myelogenous Leukemia (AML) market. A detailed picture of the Acut ... Read More
-
Anti-Glomerular Basement Membrane (Anti-GBM) Disease - Pipeline Insight, 2025
Anti-Glomerular Basement Membrane (Anti-GBM) Disease Overview ""Anti-Glomerular Basement Membrane (Anti-GBM) Disease Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anti-Glomerular Basement Membra ... Read More
-
Castleman Disease - Pipeline Insight, 2025
DelveInsight’s, “Castleman Disease– Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Castleman Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeuti ... Read More
-
Central Precocious Puberty - Pipeline Insight, 2025
DelveInsight’s, “Central Precocious Puberty – Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Central Precocious Puberty pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also co ... Read More
-
Centronuclear Myopathy- Pipeline Insight, 2025
DelveInsight’s, “Centronuclear Myopathy- Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Centronuclear Myopathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the t ... Read More
-
chemotherapy-induced bone marrow toxicities - Pipeline Insight, 2025
chemotherapy-induced bone marrow toxicities Overview ""chemotherapy-induced bone marrow toxicities Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the chemotherapy-induced bone marrow toxicities marke ... Read More
-
Functional Constipation - Pipeline Insight, 2025
Functional Constipation Overview ""Functional Constipation Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Functional Constipation market. A detailed picture of the Functional Constipation pipelin ... Read More
-
Homocystinuria - Pipeline Insight, 2025
DelveInsight’s, “Homocystinuria - Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Homocystinuria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ass ... Read More
-
Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2025
Neuropathic Pruritus & Postburn Itch Overview ""Neuropathic Pruritus & Postburn Itch Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Neuropathic Pruritus & Postburn Itch market. A detailed picture ... Read More
-
PD-1 Inhibitor - Pipeline Insight, 2025
PD-1 Inhibitor Overview ""PD-1 Inhibitor Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the PD-1 Inhibitor market. A detailed picture of the PD-1 Inhibitor pipeline landscape is provided, which inclu ... Read More
-
Punctate Epitheliopathy - Pipeline Insight, 2025
Punctate Epitheliopathy Overview ""Punctate Epitheliopathy Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Punctate Epitheliopathy market. A detailed picture of the Punctate Epitheliopathy pipelin ... Read More
-
Carpal Tunnel Syndrome - Pipeline Insight, 2025
Carpal Tunnel Syndrome Overview ""Carpal Tunnel Syndrome Pipeline Insight, 2025"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Carpal Tunnel Syndrome market. A detailed picture of the Carpal Tunnel Syndrome pipeline la ... Read More
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook